Document Detail


Cardioprotective effect of des-Aspartate-angiotensin-I (DAA-I) on cytokine gene expression profile in ligation model of myocardial infarction.
MedLine Citation:
PMID:  16423369     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We investigate the influence of des-Aspartate-angiotensin-I (DAA-I) on the cytokine expression profile in a rodent model of myocardial infarction. Myocardial infarction model was created in female Wistar rats by coronary artery ligation. Animals were randomized to receive intravenously either a daily dose of 1.2 mug DAA-I/kg body weight (group 1; n = 60) or saline (group 2; n = 60) for 14 days after infarction. Heart function was assessed by echocardiography. Animals were euthanized at 1, 3, 7, 14 and 31 days. Morphometric analysis using tetrazolium chloride staining revealed that infarct size was reduced by 32.2% (p < 0.05) in group 1 after 14 days of DAA-I treatment. Left ventricular ejection fraction in group 1 improved significantly (73.4%) as compared to group 2 (47.7%; p < 0.001). Immunostaining for immune cells at the infarct site showed that CD8+ lymphocytes infiltration at the infarct site declined in group 1 (15 +/- 5 cells) as compared to group 2 (50 +/- 6 cells; p < 0.001). Infiltration of monocytes and macrophages remained high at day 14 in group 2 (126 +/- 40 cells) as compared to group 1 (49 +/- 11 cells; p = 0.006). Multiplex PCR was done for differential gene expression of various pro-inflammatory cytokines. IL-6, TNF-alpha, TGF-beta and GM-CSF expression were significantly down-regulated in the infarct, peri-infarct and contra-lateral zones of the left ventricle in group 1 as compared to group 2. IL-6, TGF-beta and GM-CSF expression started to decline from day 1 of DAA-I treatment while TNF-alpha expression only reduced after 7 days of DAA-I treatment. We conclude that DAA-I prevented infarct expansion through suppression of inflammatory cytokines and immune cell infiltration in the infarct region.
Authors:
Abd Jalil Rufaihah; Husnain Kh Haider; Kwoon M Sim; Ping Z Ding; LiLi Beth Ramos; Shujia Jiang; Eugene K W Sim
Related Documents :
20420589 - Polyurethane scaffolds seeded with genetically engineered skeletal myoblasts: a promisi...
20713059 - Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarc...
8924519 - Intramyocardial arterial cushions of coronary vessels in animals and humans: morphology...
4073219 - Myocyte vacuolization in infarct border zones is reversible.
17541819 - Cardioprotection in stunned and hibernating myocardium.
19443059 - Effect of freshly isolated autologous tissue resident stromal cells on cardiac function...
17588439 - Surgical cryoablation for life-threatening postoperative junctional tachycardia.
16169339 - Lack of association between circulating levels of plasma oxidized low-density lipoprote...
19802729 - Effects of distal protection on left ventricular function in acute anterior myocardial ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-01-19
Journal Detail:
Title:  Life sciences     Volume:  78     ISSN:  0024-3205     ISO Abbreviation:  Life Sci.     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-02-10     Completed Date:  2006-04-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375521     Medline TA:  Life Sci     Country:  England    
Other Details:
Languages:  eng     Pagination:  1341-51     Citation Subset:  IM    
Affiliation:
Department of Cardiac, Thoracic and Vascular Surgery, National University of Singapore, Singapore.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin I / pharmacology*
Animals
Cardiotonic Agents / pharmacology*
Cytokines / genetics*
DNA Primers
Disease Models, Animal
Echocardiography
Female
Gene Expression Profiling
Gene Expression Regulation / drug effects*
Granulocyte-Macrophage Colony-Stimulating Factor / genetics
Inflammation / genetics
Myocardial Infarction / drug therapy*
Rats
Rats, Wistar
Transforming Growth Factor beta / genetics
Tumor Necrosis Factor-alpha / genetics
Chemical
Reg. No./Substance:
0/Cardiotonic Agents; 0/Cytokines; 0/DNA Primers; 0/Transforming Growth Factor beta; 0/Tumor Necrosis Factor-alpha; 83869-56-1/Granulocyte-Macrophage Colony-Stimulating Factor; 9041-90-1/Angiotensin I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sporadic amyotrophic lateral sclerosis and breast cancer: Hyaline conglomerate inclusions lead to id...
Next Document:  Influence of in vitro and in vivo insulin treatment on the hormone (histamine, serotonin, endorphin ...